Company Lookup
عربي
 
 

Market News

This Month News

This Month News

send to a friend by email

BPC posts net income of $7.93 million in 2022

2023-02-14

According to the financial statements of Birzeit Pharmaceuticals BPC for the year 2022, Net profit after tax of the period reached 7,934,039 USD Compared with Net profit after tax 12,166,341 USD for 2021, a net decrease in profit of 34.79%.Total assets of the company reached 123,003,262 USD compared with total assets of 111,975,465 USD at the end of year 2021, a net increase of 9.85%.Total liabilities of the company reached 19,489,454 USD compared with total liabilities of 19,181,029 USD at the end of year 2021, a net increase of 1.60%. Net ownership equity of the company reached 103,513,808 USD (Including Non-Controlling Interests of 923,623 USD) compared with total owner equity of 92,794,436 USD (Including Non-Controlling Interests of 929,602 USD) at the end of year 2021, a net increase of 11.55%.Noting that paid-in capital increased from 19,382,449 USD in year 2021 to 38,764,898 USD of this year,a net increase of 100.00%.

 


 

2024-04-18
Al-Quds Index increases amid growing in the dividends proposals momentum for 2023

2024-04-15
TPIC proposes distributing 5% stocks dividends for the year 2023

2024-04-14
PIBC recommends distributing 2.5641% stocks dividends for the year 2023

2024-04-14
ABRAJ recommends converting the company from public shareholding to private shareholding

2024-04-14
NCI recommends distributing 12% cash dividends for the year 2023

2024-04-04
TRUST approves distributing 10% cash dividends for the year 2023

2024-04-04
Al-Quds Index stands-still with the start of April

2024-04-03
TIC approves distributing 15% cash dividends for the year 2023

2024-04-01
NSC recommends distributing 7% stocks dividends for the year 2023

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013
PHP Notice: Undefined index: archive in C:\Inetpub\wwwroot\sahem\menu.php on line 403